CAITLIN STUDLEY: Open Payments
NPI 1114440609 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 31 payments from 14 companies in 2025. Trend: 2023 $1,464 · 2024 $1,776 · 2025 $914
Food & beverage: $914
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $224 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $151 |
| Axsome Therapeutics, Inc. | 3 | $137 |
| Vanda Pharmaceuticals Inc. | 3 | $94 |
| ABBVIE INC. | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 3 | $47 |
| Novo Nordisk Inc | 2 | $31 |
| Lilly USA, LLC | 1 | $27 |
| PFIZER INC. | 1 | $25 |
Products named: REXULTI, CAPLYTA, Auvelity, FANAPT, VRAYLAR, TRINTELLIX, SPRAVATO, Wegovy.
Industry payments across IA — which companies pay providers there.
